Journals / Dicle Tıp Dergisi / 2017 / Cilt: 44 - Sayı: 2

Histological and Biochemical Examination of the Effect of Oxytocin on Diabetic Cardiomyopathy Rat Model

Diyabetik Kardiyomiyopati Sıçan Modelinde Oksitosin Etkilerinin Histolojik ve Biyokimyasal Olarak İncelenmesi

Pages
135–143
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Results of this study show that oxytocin have positive effects on diabetic cardiomyopathy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Diabetes mellitus is a chronic metabolic disease which has caused a various cardiac disorders, has dramatically increasing prevalance in recent years.
📊
Key Findings & Data:Methods: Streptozocin are injected to 12 rats intraperitoneally (i.p.) to make them diabetic.
💡
Conclusion & Impact:Conclusion: Results of this study show that oxytocin have positive effects on diabetic cardiomyopathy.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Diabetes mellitus is a chronic metabolic disease which has caused a various cardiac disorders, has dramatically increasing prevalance in recent years. Inaccuracies of the life style and eating habits made it an important health problem. In this study, it was aimed to investigate histochemical and biochemical effects of oxytocin on cellular damage induced by hyperglycaemia in experimental rat diabetic cardiomyopathy model. Methods: Streptozocin are injected to 12 rats intraperitoneally (i.p.) to make them diabetic. No agent was injected to the rest of the rats (n = 6). Rats with blood glucose levels of 250 mg/dl and higher were included into the study. Then, 12 diabetic rats were randomly divided into 2 groups; diabetes group treated with 1 mL/kg saline and diabetes group treated with 160 ?g/kg/day oxytocin for 28 days, intraperitonally. Animals were sacrificed at the end of 28 days, then biochemical examinations were performed with cardiac puncture and histopathologic examinations were performed with myocardium. Results: It was observed that oxytocin administration in diabetic rats decreased cardiomyocyte thickness, TGF-?1 immunosuppression, TGF-?, malondialdehyde and pentraxin-3 levels. Conclusion: Results of this study show that oxytocin have positive effects on diabetic cardiomyopathy.

Özet

Amaç: Son yıllarda prevalansı hızla artan, çeşitli kardiyak bozukluklara neden olan Diyabetes mellitus kronik metabolik bir hastalıktır. Sedanter yaşam şekli ve beslenme alışkanlıklarındaki yanlışlıklara bağlı olarak önemli bir sağlık problemi haline gelmiştir. Bu çalışmada, deneysel sıçan diyabetik kardiyomiyopati modelinde hiperglisemi ile oluşturulmuş hücresel hasar üzerinde oksitosin etkilerinin histolojik ve biyokimyasal olarak incelenmesi amaçlanmıştır. Yöntemler: On iki adet sıçanın intraperitoneal (i.p) streptozosin enjeksiyonu ile diyabetik olmaları sağlandı. Sıçanların geri kalanına (n=6) herhangi bir verilmedi. Çalışma kapsamına 250 mg/dl ve daha yüksek kan şekeri düzeylerine sahip olan diyabetik kabul edilerek çalışmaya alındı. Daha sonra, diyabetik hale getirilmiş olan sıçanlar (n=12) rastgele, 1 mL/kg salin ile tedavi edilen diyabet grubu ve 28 gün boyunca 160 ?g/kg/gün i.p oksitosin ile tedavi edilen diyabet grubu olmak üzere 2 gruba ayrıldı. Hayvanlar 28 günün sonunda sakrifiye edilip kalpten alınan kan ile biyokimyasal analizler, kalp kasından da histopatolojik incelemeler yapıldı. Bulgular: Diyabetik sıçanlarda oksitosin uygulaması ile histolojik olarak kardiyomiyosit kalınlığının azaldığı, biyokimyasal olarak ise TGF-?1 immünoekspresyonun, TGF-?, malondialdehit ve pentraxin-3 seviyelerinin azaldığı gözlemlenmiştir. Sonuç: Bu çalışmada elde edilen bulgular oksitosinin diyabetik kardiyomiyopatide olumlu etkilerinin olabileceğini göstermektedir.

🔖

Cite This Article

ÇAVUŞOĞLU, T., ÇİFTÇİ, Ö. D., ÇAĞILTAY, E., MERAL, A., KIZILOĞLU, İ., GÜRGÜL, S., UYANIKGİL, Y., ERBAS, O. (2017). Histological and Biochemical Examination of the Effect of Oxytocin on Diabetic Cardiomyopathy Rat Model. Dicle Tıp Dergisi, Cilt: 44 - Sayı: 2, 135–143. https://ajindex.com/articles/200319

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999;48:937-42.
  2. Rubler S, Dlugash J, Yuceoglu YZ, et al. New type of cardiomyopathy glomerulosclerosis. Am J Cardiol 1972;30:595-602. Brownlee M. Negative consequences of glycation. Metabolism 2000;49:9-13.
  3. Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 1991;10:339-52.
  4. Cai L, Kang YJ. Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol 2001;1:181-193.
  5. Frustaci A, Kajstura J, Chimenti C, et al. Myocardial cell death in human diabetes. Circ Res 2000;87:1123-32.
  6. Sharma AK, Srinivasan BP. Triple verses glimepiride plus metformin therapy on cardiovascular risk biomarkers and diabetic cardiomyopathy in insulin resistance type 2 diabetes mellitus rats. Eur J Pharm Sci 2009;38:433-44. van den Brom CE, Huisman MC, Vlasblom R, et al. Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography. Cardiovasc Diabetol 2009;8:39. Chatham JC, Forder JR. A 13-C NMR study of glucose oxidation in the intact functioning rat heart following diyabetes-induced cardiomyopathy. J Mol Cell Cardiol 1993;10:1203-13.
  7. Cosentino F, Eto M, De Paolis P, et al. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 2003;107:1017-23.
  8. Camici GG, Schiavoni M, Francia P, et al. Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc Natl Acad Sci USA 2007;104:5217-22.
  9. Bhimji S, Godin DV, McNeill JH. Myocardial ultrastructural changes in alloxan-induced diyabetes in rabbits. Acta Anat (Basel) 1986;125:195-200. Erbaş O. Oksitosinin fizyolojik etkileri ve klinik uygulama alanları. Izm Univ Med J 2013;1:43-53.
  10. Hayat SA, Patel B, Khattar RS, et al. Diabetic cardiomyopathy: treatment. Clin Sci (Lond). 2004;107:539-57. diagnosis and Avendano GF, Agarwal RK, Bashey RI, et al. Effects of glucose intolerance on myocardial function and collagen-linked glycation. Diabetes 1999;48:1443-7.
  11. Eguchi K, Boden-Albala B, Jin ZZ, et al. Association between diabetesmellitus and left ventricular hypertrophy in a multiethnic population. Am J Cardiol 2008; 101:1787-91.
  12. Wold LE, Ceylan-Isık AF, Fang CX, et al. Metallothionein alleviates cardiac d